Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Dawn R. Cochrane"'
Autor:
Michael S. Anglesio, Kimberly C. Wiegand, Nataliya Melnyk, Christine Chow, Clara Salamanca, Leah M. Prentice, Janine Senz, Winnie Yang, Monique A. Spillman, Dawn R. Cochrane, Karey Shumansky, Sohrab P. Shah, Steve E. Kalloger, David G. Huntsman
Publikováno v:
PLoS ONE, Vol 8, Iss 10 (2013)
Externí odkaz:
https://doaj.org/article/3e05bbe9df9f4a00b1cc12e0af169ecb
Autor:
Jutta Huvila, Dawn R Cochrane, Monica Ta, Christine Chow, Kendall Greening, Samuel Leung, Anthony N Karnezis, Analisa DiFeo, David G Huntsman
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 7, Iss 6, Pp 548-555 (2021)
Abstract Ovarian carcinoma histotypes are distinct diseases with variable clinical outcomes and response to treatment. There is a need for new subtype‐specific treatment modalities, especially for women with widespread and chemo‐resistant disease
Externí odkaz:
https://doaj.org/article/d0a536b413fe4de3a25e878efa4fee34
Autor:
Jessica A Pilsworth, Dawn R Cochrane, Samantha J Neilson, Bahar H Moussavi, Daniel Lai, Aslı D Munzur, Janine Senz, Yi Kan Wang, Sina Zareian, Ali Bashashati, Adele Wong, Jacqueline Keul, Annette Staebler, Hannah S vanMeurs, Hugo M Horlings, Stefan Kommoss, Friedrich Kommoss, Esther Oliva, Anniina EM Färkkilä, Blake Gilks, David G Huntsman
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 7, Iss 3, Pp 243-252 (2021)
Abstract Adult‐type granulosa cell tumors (aGCTs) account for 90% of malignant ovarian sex cord‐stromal tumors and 2–5% of all ovarian cancers. These tumors are usually diagnosed at an early stage and are treated with surgery. However, one‐th
Externí odkaz:
https://doaj.org/article/119bf70995b744d0addb4d02ce2fc2fa
Autor:
Jennifer K. Richer, Monique A. Spillman, Russell R. Broaddus, Xian Lu, Miriam D. Post, Nicole S. Spoelstra, Annie Jean, Dawn R. Cochrane, Erin N. Howe, Irina Dimitrova, Diana M. Cittelly
PDF file - 100K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::369fafd010639352e241813abb1e8f4b
https://doi.org/10.1158/1535-7163.22498827
https://doi.org/10.1158/1535-7163.22498827
Autor:
Jennifer K. Richer, Monique A. Spillman, Russell R. Broaddus, Xian Lu, Miriam D. Post, Nicole S. Spoelstra, Annie Jean, Dawn R. Cochrane, Erin N. Howe, Irina Dimitrova, Diana M. Cittelly
PDF file - 1005K, Restoration of miR-200c results in decreased proliferation and decreased ZEB expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::509f9b7f95ca6a80c7a2484ec3142052
https://doi.org/10.1158/1535-7163.22498836.v1
https://doi.org/10.1158/1535-7163.22498836.v1
Autor:
Jennifer K. Richer, Monique A. Spillman, Russell R. Broaddus, Xian Lu, Miriam D. Post, Nicole S. Spoelstra, Annie Jean, Dawn R. Cochrane, Erin N. Howe, Irina Dimitrova, Diana M. Cittelly
PDF file - 221K, Restoration of miR-200c to ovarian cancer cells reduces βIII-tubulin expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7d647701e24ac9649b06a298a6f2ecc
https://doi.org/10.1158/1535-7163.22498833.v1
https://doi.org/10.1158/1535-7163.22498833.v1
Autor:
Jennifer K. Richer, Monique A. Spillman, Russell R. Broaddus, Xian Lu, Miriam D. Post, Nicole S. Spoelstra, Annie Jean, Dawn R. Cochrane, Erin N. Howe, Irina Dimitrova, Diana M. Cittelly
PDF file - 235K, Tumor burden at day 6, miR-200c levels and ZEB expression in tumors of mice treated with paclitaxel and miR-200c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30830ec94a9e8130ddb3faa0bdceba5c
https://doi.org/10.1158/1535-7163.22498830.v1
https://doi.org/10.1158/1535-7163.22498830.v1
Autor:
David G. Huntsman, Yemin Wang, Patrick Pirrotte, Lynn Hoang, Jeffrey M. Trent, Bernard E. Weissman, C. Blake Gilks, Jessica N. McAlpine, Gregg B. Morin, Anthony Karnezis, Friedrich Kommoss, Gian Luca Negri, Shane Colborne, Christine Chow, Angela Cheng, Samuel Leung, David Farnell, Isabel N. Alcazar, Khyatiben V. Pathak, Germain Ho, Shary Yutin Chen, Basile Tessier-Cloutier, Dawn R. Cochrane, Jennifer X. Ji
IC50 curves for ADI-PEG20 in ovarian cancer cell lines. A, ASS1-deficient ovarian cancer cell lines and B, ASS1-proficient ovarian cancer cell lines.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46794180a6c751c70173379dcc9a90af
https://doi.org/10.1158/1078-0432.22477652
https://doi.org/10.1158/1078-0432.22477652
Autor:
David G. Huntsman, Yemin Wang, Patrick Pirrotte, Lynn Hoang, Jeffrey M. Trent, Bernard E. Weissman, C. Blake Gilks, Jessica N. McAlpine, Gregg B. Morin, Anthony Karnezis, Friedrich Kommoss, Gian Luca Negri, Shane Colborne, Christine Chow, Angela Cheng, Samuel Leung, David Farnell, Isabel N. Alcazar, Khyatiben V. Pathak, Germain Ho, Shary Yutin Chen, Basile Tessier-Cloutier, Dawn R. Cochrane, Jennifer X. Ji
Table containing proteins differentially expressed in at least two rarer ovarian cancer subtypes when compared to HGSC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3a61d9d25387e33226e990e44d79974
https://doi.org/10.1158/1078-0432.22477646
https://doi.org/10.1158/1078-0432.22477646
Autor:
David G. Huntsman, Yemin Wang, Patrick Pirrotte, Lynn Hoang, Jeffrey M. Trent, Bernard E. Weissman, C. Blake Gilks, Jessica N. McAlpine, Gregg B. Morin, Anthony Karnezis, Friedrich Kommoss, Gian Luca Negri, Shane Colborne, Christine Chow, Angela Cheng, Samuel Leung, David Farnell, Isabel N. Alcazar, Khyatiben V. Pathak, Germain Ho, Shary Yutin Chen, Basile Tessier-Cloutier, Dawn R. Cochrane, Jennifer X. Ji
Purpose:Many rare ovarian cancer subtypes, such as small-cell carcinoma of the ovary, hypercalcemic type (SCCOHT), have poor prognosis due to their aggressive nature and resistance to standard platinum- and taxane-based chemotherapy. The development
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17171ef2dce12814d32cadf58c7fd6b0
https://doi.org/10.1158/1078-0432.c.6529718
https://doi.org/10.1158/1078-0432.c.6529718